EGFR and pancreatic ductal adenocarcinoma: The activation of STAT3 in pancreatic ductal adenocarcinoma is associated with autocrine and/or paracrine epidermal growth factor receptor signalling, since the selective inhibition of epidermal growth factor receptor results in a loss of activated STAT3 expression.